Emerging contaminants (ECs), such as personal care products (PCPs), endocrine disrupting
compounds (EDCs), pharmaceuticals (PhACs) and their transformation products, whose …

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the
same pharmaceutical have identical physicochemical properties, but may exhibit differences …

The escalating introduction of pesticides/veterinary drugs into the environment has
necessitated a rapid evaluation of their potential risks to ecosystems and human health. The …

The detection of new pollutants, stricter environmental regulations, and advancements in
treatment technologies are driving improvements in bioprocesses for treating wastewater …

Veterinary drugs used for treatment and prevention of diseases in animals represent
important source of environmental pollution due to intensive agri-and aquaculture …

Global pharmaceutical consumption is rising with the growing and ageing human population
and more intensive food production. Recent studies have revealed pharmaceutical residues …

In this study, a 1200 L outdoor pilot scale microalgal photobioreactor (PBR) was used for
toilet wastewater (WW) treatment and evaluate its ability to remove pharmaceutically active …

Present technologies for wastewater treatment do not sufficiently address the increasing
pollution situation of receiving water bodies, especially with the growing use of personal …

Active pharmaceutical ingredients (APIs) can enter the natural environment during
manufacture, use and/or disposal, and consequently public concern about their potential …

The occurrence of emerging micropollutants (pharmaceuticals, pesticides, personal care
products, industrial compounds, etc.) in the environment is considered a major threat to …